The Office of Inspector General (OIG)—the government watchdog charged with bettering performance and efficiencies within the Department of Transportation—in June announced a series of audits to evaluate the effectiveness of drug-testing-program oversight in the transportation sector. The first report released reveals deficiencies in the way the FAA’s Drug Abatement Division prioritizes certificate-holder inspections. The closer look was prompted by the National ...

THIS CONTENT REQUIRES SUBSCRIPTION ACCESS

You must have an Aviation Week Intelligence Network (AWIN) account or subscribe to this Market Briefing to access "Office Of Inspector General Finds Deficiencies In FAA Oversight".

 

Current Aviation Week Intelligence Network (AWIN) enterprise and individual members: please go to http://awin.aviationweek.com for access.

 

Not currently a subscriber? Click on the "Learn More" button below to view subscription offers.

Already registered? here.